Pain relief shot for hysterectomy patients put on hold
NCT ID NCT05823363
First seen Apr 09, 2026 · Last updated Jun 23, 2026 · Updated 11 times
Summary
This study aimed to see if injecting Exparel (a long-acting painkiller) into the vaginal cuff before a minimally invasive hysterectomy could lower pain scores. Participants would have reported pain levels and medication use. However, the trial was withdrawn before any patients enrolled, so no data was collected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Maimonides Medical Center
Brooklyn, New York, 11219, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Exparel (liposomal bupivacaine) mixed with bupivacaine
What this could lead to
If it worked, this could offer a way to reduce pain after hysterectomy without strong opioids.
What could go wrong
The trial was withdrawn before enrolling anyone, so no results are available. Even if run, it was a small Phase 4 study testing a known drug for a new use, so benefits may be modest.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.